Wire Stories
-
522Southeast Asian Buy Now Pay Later Market Opportunities: Market Expansion, Technology Capability and Large Partner Ecosystem to Continue Transformational Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Southeast Asian Buy Now Pay Later Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. The payments industry is now...
-
617
Firstsource Named Best in KLAS� for Eligibility and Enrollment Services
#1 Ranking Highlights Positive Customer Feedback on Firstsource�s Digital Solutions for Provider Organizations MUMBAI, India & LOUISVILLE, Ky.–(BUSINESS WIRE)–Firstsource Solutions Limited (NSE:...
-
545
Intertek Acucert is First Lab in India Accredited to ISO/IEC 17025:2017
Demonstrates technical competence to produce valid and reliable test results MUMBAI, India–(BUSINESS WIRE)–Intertek, a Total Quality Assurance provider to industries worldwide, is...
-
526
Intertek Acucert is First Lab in India Accredited to ISO/IEC 17025:2017
Demonstrates technical competence to produce valid and reliable test results MUMBAI, India–(BUSINESS WIRE)–Intertek, a Total Quality Assurance provider to industries worldwide, is...
-
588
Jam City to Drop Champions: Ascension NFTs This Week, Announces Price and Holder Perks
Limited release of 10,000 Prime Eternals to be sold in whitelist-only private sale on Feb. 24 and public sale on Feb. 25...
-
465
Jam City to Drop Champions: Ascension NFTs This Week, Announces Price and Holder Perks
Limited release of 10,000 Prime Eternals to be sold in whitelist-only private sale on Feb. 24 and public sale on Feb. 25...
-
647
HighTide Therapeutics Announces End-of-Phase 2 Meeting with FDA and Agreement to Proceed to Phase 3 for HTD1801 for the Treatment of PSC
SHENZHEN, China & ROCKVILLE, Md.–(BUSINESS WIRE)–HighTide Therapeutics, Inc. (�HighTide�), a clinical-stage biopharmaceutical company developing treatments for chronic liver / gastrointestinal diseases and...
-
484
HighTide Therapeutics Announces End-of-Phase 2 Meeting with FDA and Agreement to Proceed to Phase 3 for HTD1801 for the Treatment of PSC
SHENZHEN, China & ROCKVILLE, Md.–(BUSINESS WIRE)–HighTide Therapeutics, Inc. (�HighTide�), a clinical-stage biopharmaceutical company developing treatments for chronic liver / gastrointestinal diseases and...
-
551
Wisk Aero Partners with Long Beach to Make Advanced Air Mobility a Reality in Southern California
New partnership to create an Advanced Air Mobility (AAM) working group focused on evaluating, planning, and implementing AAM services, with a focus...
-
625
Wisk Aero Partners with Long Beach to Make Advanced Air Mobility a Reality in Southern California
New partnership to create an Advanced Air Mobility (AAM) working group focused on evaluating, planning, and implementing AAM services, with a focus...
